TY - JOUR
T1 - Altered Glucose Metabolism in Fibroblasts from Patients with Alzheimer's Disease
AU - Sims, N. R.
AU - Finegan, J. M.
AU - Blass, J. P.
PY - 1985/9/5
Y1 - 1985/9/5
N2 - To the Editor: Studies over the past decade have made major advances in defining the brain cells that are vulnerable in Alzheimer's disease1,2 but not the mechanisms producing cell loss. The major identified risk factor is genetic.3,4 Reports of molecular or cellular abnormalities in nonneural tissues, including cultured cells, raise the possibility that other tissues may express genetically determined alterations, which are clinically important only in the brain.5 (A number of inborn errors provide precedents.) Because of reports of abnormalities in glucose utilization in the brain in Alzheimer's disease,6 we compared lactate production and the oxidation of [U-14C]glucose.
AB - To the Editor: Studies over the past decade have made major advances in defining the brain cells that are vulnerable in Alzheimer's disease1,2 but not the mechanisms producing cell loss. The major identified risk factor is genetic.3,4 Reports of molecular or cellular abnormalities in nonneural tissues, including cultured cells, raise the possibility that other tissues may express genetically determined alterations, which are clinically important only in the brain.5 (A number of inborn errors provide precedents.) Because of reports of abnormalities in glucose utilization in the brain in Alzheimer's disease,6 we compared lactate production and the oxidation of [U-14C]glucose.
UR - http://www.scopus.com/inward/record.url?scp=0021849778&partnerID=8YFLogxK
U2 - 10.1056/NEJM198509053131013
DO - 10.1056/NEJM198509053131013
M3 - Letter
C2 - 4022053
AN - SCOPUS:0021849778
SN - 0028-4793
VL - 313
SP - 638
EP - 639
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 10
ER -